Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acadia Healthcare CoMIL:1ACHC 49 Debt-to-EBITDA is 5.80 as of Jun. 2026, which is 13% below its 10-year median of 6.64. GuruFocus rates MIL:1ACHC with a GF Score™ of 49/100 and a GF Value™ of €37.64 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Acadia Healthcare Co ranks worse than 209204.81% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Acadia Healthcare Co's Debt-to-EBITDA or its related term are showing as below:
MIL:1ACHC'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.58 Med: 6.64 Max: 9.61
Current: -3.42
During the past 13 years, the highest Debt-to-EBITDA Ratio of Acadia Healthcare Co was 9.61. The lowest was -3.58. And the median was 6.64.
MIL:1ACHC's Debt-to-EBITDA is ranked worse than 100% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs MIL:1ACHC: -3.42
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Acadia Healthcare Co Debt-to-EBITDA Related Terms
Acadia Healthcare Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Acadia Healthcare Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1ACHC vs OPCH, NHC, BKD: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Acadia Healthcare Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acadia Healthcare Co Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acadia Healthcare Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Acadia Healthcare Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Acadia Healthcare Co (MIL:1ACHC) has a Debt-to-EBITDA of 5.80 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Acadia Healthcare Co. This is 13% below median its historical median of 6.64. According to the industry distribution chart, Acadia Healthcare Co ranks #999999 out of 478 companies in the Healthcare Providers & Services industry.
Is Acadia Healthcare Co's Debt-to-EBITDA too high?
Acadia Healthcare Co's current Debt-to-EBITDA of 5.80 is 13% below median its 10-year median of 6.64. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Acadia Healthcare Co's value of 5.80 is 165.4% above this industry median. Based on the distribution chart, Acadia Healthcare Co ranks #999999 out of 478 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Acadia Healthcare Co has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acadia Healthcare Co's Debt-to-EBITDA compare to OPCH and NHC?
According to the Healthcare Providers & Services industry distribution chart, Acadia Healthcare Co ranks #999999 out of 478 companies for Debt-to-EBITDA. This places Acadia Healthcare Co in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Acadia Healthcare Co's value of 5.80 is 165.4% above this benchmark. While the company's 10-year median is 6.64 vs. the industry median of 2.19, Acadia Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acadia Healthcare Co's current Debt-to-EBITDA of 5.80 is 165.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Acadia Healthcare Co. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acadia Healthcare Co's current Debt-to-EBITDA is 5.80, which is 13% below median its own 10-year median of 6.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acadia Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Acadia Healthcare Co (MIL:1ACHC) is currently considered Modestly Undervalued. The stock's GF Value™ is €37.64, compared to a current price of €27.40 — trading 27.2% below its estimated fair value. The current Debt-to-EBITDA is 5.80, which is 13% below median its 10-year median of 6.64 and 165.4% above the Healthcare Providers & Services industry median of 2.19. Acadia Healthcare Co's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Acadia Healthcare Co (MIL:1ACHC), the current Debt-to-EBITDA is 5.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acadia Healthcare Co (MIL:1ACHC) Overvalued in 2026?
Based on GuruFocus' analysis, Acadia Healthcare Co stock appears to be undervalued.
The current stock price of €27.40 is trading 27.2% below its estimated GF Value™ of €37.64.
GuruFocus considers Acadia Healthcare Co to be Modestly Undervalued.
Key valuation signals for MIL:1ACHC:
Debt-to-EBITDA: 5.80 (13% below median its 10-year median of 6.64)
GF Value™: €37.64 vs. price of €27.40 (27.2% below fair value)
Industry Position: 165.4% above the Healthcare Providers & Services median (#999999 of 478)
No single metric tells the full story. See the MIL:1ACHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
49GF Score
Get the complete analysis for MIL:1ACHC
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1ACHC has been successfully added to your 
